Dermatomyositis

  • Jerry C. Jacobs

Abstract

Dermatomyositis is a disease of the connective tissues that is characterized primarily by inflammation of skin and muscles. It is uncommon but not rare. Despite its initial description in 1887, the disease went virtually unnoticed in children until Wedgwood et al. (1953)1 and Banker and Victor (1966)2 kindled new interest with their pioneering clinical and pathologic studies. Since that time, there have been an increasing number of clinical reports and a few efforts at etiologic definition.

Keywords

Celiac Disease Inclusion Body Myositis Inflammatory Myopathy Muscle Enzyme Coxsackie Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wedgwood RJP, Cook CD, Cohen J: Dermatomyositis: report of 26 cases, in children with a discussion of endocrine therapy in 13. Pediatrics 12: 447–466, 1953.PubMedGoogle Scholar
  2. 2.
    Banker BQ, Victor M: Dermatomyositis (systemic angiopathy) of childhood. Medicine 45: 261–289, 1966.PubMedGoogle Scholar
  3. 3.
    Ackerman AB: Histologic Diagnosis of Inflammatory Skin Diseases. Lea and Febiger, Philadelphia, 1978.Google Scholar
  4. 4.
    Silver RM, Maricq HR: Childhood dermatomyositis: serial microvascular studies. Pediatrics 83: 278–283, 1989.PubMedGoogle Scholar
  5. 5.
    Crowe WE, Bove KE, Levinson JE, et al.: Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis. Arthritis Rheum 25: 126–139, 1982.PubMedGoogle Scholar
  6. 6.
    Whitaker JN, Engel WK: Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy. N Engl J Med 286: 333–338, 1972.PubMedGoogle Scholar
  7. 7.
    Kissel JT, Mendrell JR, Rammonohan KW: Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 314: 329334, 1986.Google Scholar
  8. 8.
    Miller FW: Humoral immunity and immunogenetics in the idiopathic inflammatory myopathies. Curr Opin Rheumatol 3: 902–910, 1991.PubMedGoogle Scholar
  9. 9.
    Dawkins RL, Mastaglis FL: Cell-mediated cytotoxicity to muscle in polymyositis. N Engl J Med 288: 434–438, 1973.PubMedGoogle Scholar
  10. 10.
    Kalovidouris AE, Pourmand R, Passo MH, Plotkin Z: Proliferative response of peripheral blood mononuclear cells to autologous and allogenetic muscle in patients with polymyositis/dermatomyositis. Arthritis Rheum 32: 446–453, 1989.PubMedGoogle Scholar
  11. 11.
    Fudman EJ, Schnitzer TJ: Clinical and biochemical characteristics of autoantibody system in polymyositis and dermatomyositis. Semin Arthritis Rheum 15: 255–260, 1986.PubMedGoogle Scholar
  12. 12.
    Saito E, Murabayashi K, Ogawa T, et al.: Etiological difference between dermatomyositis and polymyositis. Jap J Rheumatol 3: 85–93, 1991.Google Scholar
  13. 13.
    Kalovidouris AE: The role of cell-mediated immunity in polymyositis. Curr Opin Rheumatol 3: 911–918, 1991.PubMedGoogle Scholar
  14. 14.
    Hohlfeld R, Engel AG, Li K, Harper MC: Polymyositis mediated by T lymphocytes that express the gamma/delta receptor. N Engl J Med 324: 877–881, 1991.PubMedGoogle Scholar
  15. 15.
    Friedmen JN, Pachman LM, Mary jowski KL, et al.: Immunogenetic studies of juvenile dermatomyositis: HLA-DR antigen frequencies. Arthritis Rheum 26: 214–216, 1983.Google Scholar
  16. 16.
    Carroll JE, Silverman A, Isobe Y, et al.: Inflammatory myopathy, IgA deficiency, and intestinal malabsorption. J Pediatr 89: 216–219, 1976.PubMedGoogle Scholar
  17. 17.
    Leddy JP, Griggs RC, Klemperer MR, et al.: Hereditary complement (C2) deficiency with dermatomyositis. Am J Med 58: 83–91, 1975.PubMedGoogle Scholar
  18. 18.
    Hennekam RCM, Hiemstra I, Jennekens FGI, Kuis W: Juvenile dermatomyositis in first cousins. N Engl J Med 323: 199, 1990.PubMedGoogle Scholar
  19. 19.
    Reed AM, Ober C, Pachman LM: Increased risk for juvenile dermatomyositis (JDMS) is associated with HLA-DQA1. Arthritis Rheum 33:S15, 1990. 19a.Liblau R, Morel E, Bach J-F: Autoimmune diseases, IgA deficiency, and intravenous immunoglobulin treatment. Am J Med 93: 114–115, 1992.Google Scholar
  20. 20.
    Harati Y, Niakan E, Bergman EW: Childhood dermatomyositis in monozygotic twins. Neurology 36: 721–723, 1986.PubMedGoogle Scholar
  21. 21.
    Walker EJ, Jeffrey PD: Polymyositis and molecular mimicry, a mechanism of autoimmunity. Lancet 2: 605–608, 1986.PubMedGoogle Scholar
  22. 22.
    Garcia-de-la-Torre I, Ramirez-Casillas A, Hernandez-Vazques L: Acute familial myositis with a common autoimmune response. Arthritis Rheum 34: 744750, 1991.Google Scholar
  23. 23.
    Ytterberg SR, Mahowald ML, Messner RP: Coxsackie virus B1-induced polymyositis. Lack of disease expression in nu/nu Mice. J Clin Invest 80: 499506, 1987.Google Scholar
  24. 24.
    Yousef GE, Isenberg DA, Mowbray JF: Detection of enterovirus specific RNA sequences in muscle biopsy specimens from patients with adult onset myositis. Ann Rheum Dis 49: 310–315, 1990.PubMedGoogle Scholar
  25. 25.
    Christensen ML, Pachman LM, Schneiderman R, et al.: Prevalence of Coxsackie-B virus antibodies in patients with juvenile dermatomyositis. Arthritis Rheum 29: 1365–1370, 1986.PubMedGoogle Scholar
  26. 26.
    Bowles NE, et al.: Dermatomyositis, polymyositis, and Coxsackie-B virus infection. Lancet 1: 1004, 1987.PubMedGoogle Scholar
  27. 27.
    LivesonJA, Spielholz NI: Peripheral Neurology; Case Studies in Electrodiagnosis. Davis, Philadelphia, 1979.Google Scholar
  28. 28.
    Bohan A, Peter JB, Bowman RL, et al.: A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 56: 255–286, 1977.PubMedGoogle Scholar
  29. 29.
    Spencer-Green G, Schlesinger M, Bove KE, et al.: Nailfold capillary abnormalities in childhood rheumatic disease. J Pediatr 102: 341–346, 1983.PubMedGoogle Scholar
  30. 30.
    Bowyer SL, Blane CE, Sullivan DB, Cassidy JT: Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification. J Pediatr 103: 882–888, 1983.PubMedGoogle Scholar
  31. 31.
    DiLiberti JH, D’Agostino AN, Cole G: Needle muscle biopsy in infants and children. J Pediatr 103: 566–570, 1983.PubMedGoogle Scholar
  32. 32.
    Hernandez RJ, Keim DR, Sullivan DB, et al.: Magnetic resonance imaging appearance of the muscles in childhood dermatomyositis. J Pediatr 117: 546550, 1990.Google Scholar
  33. 33.
    de Merieux P, Verity A, Clements PJ, Paulus HE: Esophageal abnormalities and dysphagia in polymyositis and dermatomyositis. Arthritis Rheum 26: 96 1968, 1983.Google Scholar
  34. 34.
    Fischer TJ, Cipel L, Stiehm ER. Pneumotosis intestinalis associated with fatal childhood dermatomyositis. Pediatrics 61: 127–130, 1978.PubMedGoogle Scholar
  35. 35.
    Schullinger JN, Jacobs JC, Berdon WE: Diagnosis and management of gastrointestinal perforations in childhood dermatomyositis with particular reference to perforations of the duodenum. J Pediatr Surg 123: 1117–1119, 1988.Google Scholar
  36. 36.
    Downey EC, Woolley MM, Hanson V: Required surgical therapy in the pediatric patient with dermatomyositis. Arch Surg 123: 1117–1120, 1988.PubMedGoogle Scholar
  37. 37.
    Dickey BF, Myers AR: Pulmonary disease in polymyositis/dermatomyositis. Semin Arthritis Rheum 14: 60–76, 1984.PubMedGoogle Scholar
  38. 38.
    Singsen BH, Tedford JC, Platzker ACG, et al.: Spontaneous pneumothorax: a complication of juvenile dermatomyositis. J Pediatr 92: 771–774, 1978.PubMedGoogle Scholar
  39. 39.
    Schwartz MI, Matthay RA, Sahn SA, et al.: Interstitial lung disease in polymyositis and dermatomyositis: analysis of six cases and review of the literature. Medicine 55: 89–104, 1976.Google Scholar
  40. 40.
    Jacobs JC: Methotrexate and azathioprine treatment of childhood dermatomyositis. Pediatrics 59: 212–218, 1977.PubMedGoogle Scholar
  41. a.Pereira RM, Lerner S, Maeda WT et al.: Pericardial tamponade in juvenile dermatomyositis. Clin Cardiol 15: 301–303, 1992.Google Scholar
  42. 41.
    Gottdiener JS, Sherber HS, Hawley RJ, et al.: Cardiac manifestations in polymyositis. Am J Cardiol 41: 1141–1144, 1978.PubMedGoogle Scholar
  43. 42.
    Bruce GM: Retinitis in dermatomyositis. Trans Am Ophthalmol Soc 32: 28 2295, 1938.Google Scholar
  44. 43.
    Fruman LS, Ragsdale CG, Sullivan DB, et al.: Retinopathy in juvenile dermatomyositis. J Pediatr 88: 267–269, 1976.PubMedGoogle Scholar
  45. 44.
    Bitnum S, Daeschner CW, Travis LB, et al.: Dermatomyositis. J Pediatr 64: 101–131, 1964.PubMedGoogle Scholar
  46. 45.
    Pirovino M, Neff MS, Sharon E: Myoglobinuria and acute renal failure with acute polymyositis. NY State J Med 79: 764–767, 1979.Google Scholar
  47. 46.
    Kagen LJ: Myoglobinemia in inflammatory myopathies. JAMA 237: 1448 1452, 1977.Google Scholar
  48. 47.
    Miller JJ: Late progression in dermatomyositis in childhood. J Pediatr 83: 543548, 1973.Google Scholar
  49. 48.
    Skuterud E, Sydnes OA, Haavik TK: Calcinosis in dermatomyositis treated with probenecid. Scand J Rheum 10: 92–94, 1981.PubMedGoogle Scholar
  50. 49.
    Burger RG, Featherstone GL, Raasch RHE, et al.: Treatment of calcinosis universalis with low-dose warfarin. Am J Med 83:72–75, 1987 (see also correspondence 84: 795–796, 1988 ).Google Scholar
  51. 50.
    Steiner RM, Glassman L, Schwartz MW, et al.: The radiologic findings in dermatomyositis of childhood. Radiology 111: 385–393, 1974.PubMedGoogle Scholar
  52. 51.
    Wilscher ML, Holdawat IM, North JDK: Hypercalcaemia during resolution of calcinosis in juvenile dermatomyositis. Br Med J 288: 1345, 1984.Google Scholar
  53. a.Moore EC, Cohen F, Douglas SD, Gutta V: Staphylococcal infections in childhood dermatomyositis—association with the development of calcinosis, raised IgE concentrations and granulocyte chemotactic defect. Ann Rheum Dis 51: 378–383, 1992.Google Scholar
  54. 52.
    Spencer CH, Hanson V, Singsen BH, et al.: Course of treated juvenile dermatomyositis. J Pediatr 105: 399–408, 1984.PubMedGoogle Scholar
  55. a.Oddis CV: Therapy for myositis. Curr Opin Rheumatol 3: 919–924, 1991.Google Scholar
  56. 53.
    Ames EL, Posch JL: Calcinosis of the flexor and extensor tendons in dermatomyositis. Case Report. J Hand Surg 9A: 876–879, 1984.Google Scholar
  57. 54.
    Chalmers A, Sayson R, Walters K: Juvenile dermatomyosisits: medical, social, and economic status in adulthood. Can Med Assoc J Med 314: 329–334, 1986.Google Scholar
  58. 55.
    Miller LC, Michael AF, Kim Y: Childhood dermatomyositis. Clin Pediatr 26: 561–566, 1987.Google Scholar
  59. 56.
    Wexter ID, Newman AJ, Dhams WT: Hypothyroidism occurring in patients with childhood dermatomyositis. Pediatr Res 255: 170A, 1989.Google Scholar
  60. 57.
    Tucker LB, Sadeghi-Nejad A, Schaller JG: The association of acquired lipodystrophy with juvenile dermatomyositis. Arthritis Rheum 33: 5146, 1990.Google Scholar
  61. 58.
    Sissons JG, West RJ, Fallows J, et al.: The complement abnormalities of lipodystrophy. N Engl J Med 294: 461–465, 1976.PubMedGoogle Scholar
  62. 59.
    Reaven GM: Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in the etiology and clinical course of hypertension. Am J Med 90(Suppl A):7S12S, 1991.Google Scholar
  63. a.Jacobs JC: Treatment of dermatomyositis. Arthritis Rheum 20: 338–341, 1977.Google Scholar
  64. 60.
    Teresi ME, Crom WR, Choi KE, et al.: Methotrexate bioavailability after oral and intramuscular administration in children. J Pediatr 110: 788–792, 1987.PubMedGoogle Scholar
  65. 61.
    Kula RW: In Delakas MC (ed.) Polymyositis and dermatomyositis. Butter-worths, Boston, pp. 255–279, 1988.Google Scholar
  66. 62.
    Laxer RM, Stein LD, Petty RE: Intravenous pulse methylprednisolone treatment of juvenile dermatomyositis. Arthritis Rheum 30: 328–334, 1987.PubMedGoogle Scholar
  67. 63.
    Miller FW, Leitman SF, Cronin ME et al.: Controlled trial of plasma exchange in polymyositis and dermatomyositis. N Engl J Med 326: 1380–1384, 1992.PubMedGoogle Scholar
  68. 64.
    Heckmatt J, Saunders C, Peters AM, et al.: Cyclosporin in juvenile dermatomyositis. Lancet 1063–1066, 1989.Google Scholar
  69. 65.
    Kahan BD, Conley S, Portman R, et al.: Parent-to-child transplantation with cyclosporine immunosuppression. J Pediatr 111 (6, pt. 2): 1012–1016, 1987.PubMedGoogle Scholar
  70. 65a.
    Whang R, Whang DD, Ryan MP: Refractory potassium repletion. A consequence of magnesium deficiency. Arch Intern Med 152: 40–45, 1992.PubMedGoogle Scholar
  71. b.Burack DA, Griffith BP, Thompson ME, Kahl LE: Hyperuricemia and gout among heart transplant recipients receiving cyclosporine. Am J Med 92: 141–146, 1992.Google Scholar
  72. 65c.
    Feutren G, Mihatsch MJ et al.: Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 326: 1654–1660, 1992.PubMedGoogle Scholar
  73. 66.
    Lang BA, Laxer RM, Murphy G, et al.: Treatment of juvenile dermatomyositis with intravenous gammaglobulin. Am J Med 91: 169–172, 1991.PubMedGoogle Scholar
  74. 67.
    Di Nicolo R, Hutto J, Jyonouchi H, et al.: Intravenous gammaglobulin (IVGG) improves treatment of dermatomyositis. Pediatr Res 27: 155A, 1990.Google Scholar
  75. a.Cherin P, Herson S, Wechsler B, et al.: Efficacy of Intravenous Gammaglobulin Therapy in Chronic Refractory Polymyositis and Dermatomyositis: An Open Study with 20 Adult Patients. Am J Med 91: 162–168, 1991.Google Scholar
  76. b.Dwyer JM: Manipulating the immune system with immune globulin. N Eng Med 326: 107–116, 1992.Google Scholar
  77. 67c.
    Viard J-P, Vittecoq D, Lacroix C, Bach J-F: Response of HIV-1-associated polymyositis to intravenous immunoglobulin. Am J Med 92: 580–581, 1992.PubMedGoogle Scholar
  78. 68.
    So SKS, Najarian JS, Nevins TE, et al.: Low-dose cyclosporine therapy combined with standard immunosuppression in pediatric renal transplantation. J Pediatr 11: 1017–1021, 1987.Google Scholar
  79. 69.
    Cohen MR, Sulaiman AR, Garancis JC, Wortmann RL: Clinical heterogeneity and treatment response to inclusion body myositis. Arthritis Rheum 32: 734740, 1989.Google Scholar
  80. 70.
    Case Records of the Massachusetts General Hospital. Case 40–1991 N Engl J Med 325: 1026–1035, 1991.Google Scholar
  81. 71.
    Pittsley RA, Shearn MA, Kaufmam L: Acute hepatitis B simulating dermatomyositis. JAMA 239: 959, 1978.PubMedGoogle Scholar
  82. 72.
    Dietzman DE, Schaller JG, Ray G, et al.: Acute myositis with influenza B infection. Pediatrics 57: 255–258, 1976.PubMedGoogle Scholar
  83. 73.
    Grunwald Z, Ashkenazi S, Peterbourg I, et al.: Acute transient myositis secondary to viral infection in childhood. A report of two patients and review of the literature. Intl Pediatr 6: 301–303, 1991.Google Scholar
  84. 74.
    Kelly KJ, Garland JS, Tang TT, et al.: Fatal rhabdomyolysis following influenza infection in a girl with familial carnitine palmityl transferase deficiency. Pediatrics 84: 312–316, 1989.PubMedGoogle Scholar
  85. 75.
    Drachman DA, Tuncbay TO: The remote myopathy of trichinosis. Neurology 15: 1127–1135, 1965.PubMedGoogle Scholar
  86. 76.
    Layzer RB, Shearn MA, Satya-Murti S: Eosinophilic polymyositis. Ann Neurol 1: 65–71, 1977.PubMedGoogle Scholar
  87. 77.
    Askari A, Vignos PJ, Moskowitz RW: Steroid myopathy in connective tissue disease. Am J Med 61: 485–492, 1976.PubMedGoogle Scholar
  88. 78.
    Bardelas JA, Winkelstein JA, Seto DSY, et al.: Fatal echo 24 infection in a patient with hypogammaglobulinemia: Relationship to dermatomyositis-like syndrome. J Pediatr 90: 396–399, 1977.PubMedGoogle Scholar
  89. 79.
    Crennan JM, Van Scoy RE, McKenna CH, Smith TF: Echovirus polymyositis in patients with hypogammaglobulinemia. Am J Med 81: 35–42, 1986.PubMedGoogle Scholar
  90. 80.
    Mease PJ, Ochs HD, Wedgwood PJ: Successful treatment of echovirus meningoencephalitis and myositis-fasciitis with intravenous immune globulin therapy in a patient with X-linked aggammaglobulinemia. N Engl J Med 304:1278–1281, 1981. (see also: N Engl J Med 313: 758, 1985 )Google Scholar
  91. 81.
    Herrera R, Varela E, Morales G, et al.: Dermatomyositis-like syndrome caused by Trichinae. Report of two cases. J Rheumatol 12: 782–784, 1985.PubMedGoogle Scholar
  92. 82.
    Nordstrom M, Petropolis AA, Giorno R, et al.: Inflammatory myopathy and acquired immunodeficiency syndrome. Arthritis Rheum 32: 475–479, 1989.PubMedGoogle Scholar
  93. 83.
    Walter EB, Drucker RP, McKinney RE, Wilfert CM: Myopathy in human immunodeficiency virus-infected children receiving long-term Zidovudine therapy. J Pediatr 119: 152–155, 1991.PubMedGoogle Scholar
  94. 84.
    Nevins MA, Saran M, Bright, M, et al.: Pitfalls in interpreting serum creatine phosphokinase activity. JAMA 224: 1382–1387, 1973.PubMedGoogle Scholar
  95. 85.
    Hochberg MC, Koppes GM, Edwards CQ, et al.: Hypothyroidism presenting as a polymyositis-like syndrome. Arthritis Rheum 19: 1363–1366, 1976.PubMedGoogle Scholar
  96. 86.
    Newman AJ, Lee C: Hypothyroidism simulating dermatomyositis. J Pediatr 97: 772–774, 1980.PubMedGoogle Scholar
  97. 87.
    Wortmann RL: Metabolic myopathies. Curr Opin Rheumatol 3: 925–933, 1991.PubMedGoogle Scholar
  98. 88.
    Editorial: Lipid storage myopathies. Lancet: 1: 757–758, 1978.Google Scholar
  99. 89.
    Raifman MA, Bernat M, Lenarsky C: Cold weather and rhabdomyolysis. J Pediatr 93: 970–971, 1978.PubMedGoogle Scholar
  100. 90.
    DiMauro S: Metabolic myopathies. In Vinken PJ, Bruyn GW (eds.) Handbook of Clinical Neurology. North-Holland, Amsterdam, 1992, In Press. (Vol 61, #17)Google Scholar
  101. 91.
    Tein I, DiMauro S, Rowland, LP: Myoglobinuria. In Vinken PJ, Bruyn GW (eds.) Handbook of Clinical Neurology. North-Holland, Amsterdam, 1992, In Press. (Vol 61, #17)Google Scholar
  102. 92.
    Fernandez A, Justiniani FR: Massive rhabdomyolysis: a rare presentation of primary vibrio vulnificus septicemia. Am J Med 89: 535–536, 1990.PubMedGoogle Scholar
  103. 93.
    Foulkes WD, Sewry C, Calam J, Hodgson HJF: Rhabdomyolysis after intramuscular iron-dextran in malabsorption. Ann Rheum Dis 50: 184–184, 1991.PubMedGoogle Scholar
  104. 94.
    Barnes BE: Dermatomyositis and malignancy. Ann Intern Med 84: 68–76, 1976.PubMedGoogle Scholar
  105. 95.
    Singsen BH, Waters KD, Siegel SE, et al.: Lymphocytic leukemia, atypical dermatomyositis, and hyperlipidemia in a 4 year old boy. J Pediatr 90: 602–604, 1976.Google Scholar
  106. 96.
    Zundel WS, Tyler FH: The muscular dystrophies. N Engl J Med 273:537–543; 596–601, 1965.Google Scholar
  107. 97.
    Phillips PE, Kassan SS, Kagen LJ: Increased toxoplasma antibodies in idiopathic inflammatory muscle disease. Arthritis Rheum 22: 209–214, 1979.PubMedGoogle Scholar
  108. 98.
    Fernandes L, Swinson DR, Hamilton EDB: Dermatomyositis complicating penicillamine treatment. Ann Rheum Dis 36: 94–95, 1977.PubMedGoogle Scholar
  109. 99.
    Kass E, Straume S, Munthe E: Dermatomyositis after BCG vaccination. Lancet 1: 722, 1978.Google Scholar
  110. 100.
    Taneja V, Mehra N, Singh YN, et al.: HLA-D region genes and susceptibility to D-penicillamine-induced myositis. Arthritis Rheum 33: 1445–1447, 1990.PubMedGoogle Scholar
  111. 101.
    Pierce LR, Wysowski DK, Gross TP: Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy. JAMA 264: 71–75, 1990.PubMedGoogle Scholar
  112. 102.
    Doyle DR, McCurley TL, Sergent JS: Fatal polymyositis in D-penicillamine treated rheumatoid arthritis. Ann Intern Med 98: 327–330, 1983.PubMedGoogle Scholar
  113. 103.
    Menard DB, Haddad H, Blain JG, et al.: Granulomatous myositis and myopathy associated with Crohn’s colitis. N Engl J Med 295: 818–819, 1976.PubMedGoogle Scholar
  114. 104.
    Tang TT, Sedmak GV, Siegesmund KA, et al.: Chronic myopathy associated with coxsackie virus type A9. N Engl J Med 292: 608–611, 1975.PubMedGoogle Scholar
  115. 105.
    Steinherz R, Chesney RW, Eisentstein B, et al.: Elevated serum calcitriol concentrations do not fall in response to hyperphosphatemia in familial tumoral calcinosis. Am J Dis Child 139: 816–819, 1985.PubMedGoogle Scholar
  116. 106.
    Foster CM, Levin S, Levine M, et al.: Limited dermal ossification: clinical features and natural history. J Pediatr 109: 71–76, 1986.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • Jerry C. Jacobs
    • 1
  1. 1.Section of Pediatric Rheumatology and the Regional Arthritis Program (RAP-4-Kids)Columbia-Presbyterian Medical CenterNew YorkUSA

Personalised recommendations